VertisPro AI Patient Recruitment

VertisPro (VertisPro Pte Ltd) is an AI patient acquisition company headquartered at Launchpad, Ayer Rajah Crescent, Singapore. It serves hospitals and pharma sponsors, and its website does not state a founding year.

For trials, the platform tracks real-time patient research behavior through 132 AI Curiosity Indexes to find where eligible patients live and which sites are closest. Offerings are site selection and feasibility, referral center intelligence, and multi-channel patient recruitment. The company says it operates in 30+ countries.

• Site selection and feasibility: finds where trial-eligible patients and nearby sites are.
• Referral center intelligence: shows where handoffs from sites to patients fail.
• Patient recruitment: continuous multi-channel engagement with response review.
• AI Curiosity Indexes: 132 indicators of patient research behavior.
• Provider patient flows: digital acquisition for hospitals.
• Sample report: a redacted report and methodology page available before contact.

Sponsors planning oncology or rare disease studies in Southeast Asia could use site feasibility to choose Vietnamese sites. Private hospitals in Vietnam could use patient flow services to reach trial-eligible patients.

Targets recruitment where eligible patients are located instead of historical site averages. Maps where referral handoffs fail. Runs continuous multi-channel engagement. The site claims a 53% reduction in enrollment timelines and over 95% patient retention (company figures).

Most trials miss enrollment timelines, and sponsors are looking for data-driven recruitment in Asia-Pacific where patient pools are large. Vietnam and Southeast Asia can benefit from a Singapore-based vendor with regional CRO partners.

Singapore HQ at Launchpad, Ayer Rajah Crescent. 2025-08: collaboration with Expecto Health Science, an Asia-Pacific CRO (BioSpectrum Asia). CEO Harshad Puppalwar per that article.